Announced Mon, 15 Jun · 21:49 IST
22nd AGM on July 9, 2026; ₹10 dividend recommended; FY26 annual report shared
Compliance View source PDF
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹1734.60
prior close
₹1731.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+1.2+0.8+0.7+2.8+5.8+7.4+6.6+9.8+9.8+14.5+19.6——
Up moveDown movePending
AI summary
CORONA Remedies' 22nd AGM will be held on July 9, 2026 at 11:00 AM via video conferencing. The Board (meeting held May 11, 2026) has recommended a dividend of ₹10 per equity share (face value ₹10) for FY26, subject to shareholder approval. The FY26 annual report and AGM notice are available on the company website. Letters are being sent to shareholders who haven't registered email IDs with the company or depository, per SEBI Regulation 36(1)(b).
Likely market impact
₹10/share dividend pending shareholder approval; AGM on July 9; shareholders urged to update KYC and email for electronic dividend credit.